Corporate Banner
Satellite Banner
Technology Networks Header
Friday, January 30, 2015
 
Register | Sign in
Home Page > Videos > DeNovix DS-11: Next Generation 1uL spectrophotometer for DNA, RNA & Protein
  Videos

Return

DeNovix DS-11: Next Generation 1uL spectrophotometer for DNA, RNA & Protein
DeNovix, Inc.

The patent pending DS-11 spectrophotometer rapidly quantifies 0.5 – 1.5 ul samples of nucleic acids and proteins. The stand-alone unit includes an Android™ based operating system that does not require a PC. The DS-11 meets or exceeds the performance specifications of the market leading microvolume spectrophotometer while saving space, time and money. Free one-week trials are available for US & UK* customers. DeNovix pays the shipping costs to and from your lab for evaluation. See website for details. The system features a glove compatible, 7” HD touch screen. The DS-11 includes Wi-Fi, USB, and Ethernet connectivity, allowing users to easily export data via email, a USB drive, or via an optional printer. Measurements are made using intuitive EasyApps® designed for the most common life science applications. Rapidly quantify DNA, ssDNA, RNA, purified proteins, labeled proteins, or obtain user defined spectrophotometric measurements using the pre-installed apps. The DS-11 is a full spectrum (190-840nm) UV-Vis spectrophotometer and measures the broadest concentration range of any microvolume spectrophotometer. Options include three color choices and an optional model that includes both microvolume and cuvette modes (DS-11+). With SmartPath® Technology, the DS-11 provides reliable 1uL sample results every time. The instrument's opto-mechanical components and proprietary algorithms together provide pathlength control and performance unmatched by any microvolume and spectrophotometer. Benefits of SmartPath Technology: » No recalibration time or expense » Measure proteins with confidence » Results in 4 seconds - no dilutions required » Broadest dynamic range: 0.04 - 500 AU (1 cm equivalent) Measurement range: 2.0 - 25,000 ng/µL dsDNA and 0.10 - 750 mg/ml BSA For more information about the DeNovix DS-11 Microvolume Spectrophotometer, or to locate distributors and representatives visit: http://www.denovix.com About DeNovix Inc.: DeNovix Inc., founded in 2012, is a Wilmington, DE, USA based instrumentation company that develops, manufactures and sells laboratory equipment to meet the demands of today’s evolving life science research. DeNovix focuses on providing innovative products and outstanding customer support. The company’s first product, the DS-11 Spectrophotometer, is the first stand-alone microvolume spectrophotometer that is controlled by a built-in Android™ operating system. The instrument, used for quantification of nucleic acids and proteins, features an easy to use brilliant touch screen interface, Wi-Fi and Ethernet connectivity, four-second measurement time; three color choices and two model choices. *UK trial offer not valid for Northern Ireland.

Request more information
Company product page



For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here

Scientific News
New Method For Identifying Most Aggressive Childhood Cancers
A research group at Lund University in Sweden has found a new way to identify the most malignant tumours in children. The method involves studying genetic ‘micro-variation’, rather than the presence of individual mutations.
Powerful Tool Promises To Change The Way Scientists View Proteins
Aquaria, a publicly available web resource that streamlines and simplifies the process of gleaning insight from 3D protein structures, is fast, easy-to-use and contains twice as many models as all other similar resources combined.
Rapid Test Kit Detects Dengue Antibodies from Saliva
IBN’s MedTech innovation simplifies diagnosis of infectious diseases.
“Unprecedented Sensitivity and Specificity” in Ovarian Cancer
Study of the use of the Parsortix system as a clinical application in the detection and treatment of ovarian cancer patients.
Nanoparticle Lights Up Artery-Clogging Plaque
A new imaging agent that may light up dangerous plaque in arteries is to be evaluated in a clinical trial.
Study Uncovers Range of Molecular Alterations in Head and Neck Cancers
TCGA tumor genome sequencing analyses offer new insights into the effects of HPV and smoking, and find genomic similarities with other cancers.
Beating The Clock: New Treatment For Rabies Developed
University of Georgia researchers have developed a new treatment for rabies.
New Cells May Help Treat Diabetes
UI group creates insulin-producing cells that normalize blood-sugar levels in diabetic mice.
NIH Launches Tool to Advance Down Syndrome Research
Web portal will help approved professionals to plan clinical studies.
Cancer-Causing Virus Blocks Human Immune Response
Epstein-Barr virus shown to outwit the human immune response using microRNAs.
Scroll Up
Scroll Down
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn